However, there is currently no statistically significant evidence that NPs increase rates of smoking cessation compared with other products or control. To view or add a comment, sign in USA: GLP-1s Hold Promise as Treatment for Tobacco/Nicotine Use Disorder "Recent clinical data, including both quasi-experimental studies and randomized controlled trials, have supported the use of GLP-1 receptor agonists in reducing tobacco or nicotine use, particularly among those with concomitant diabetes mellitus type II (DM2).15 A recent cross-sectional, survey-based pilot study examined cigarette smoking among individuals with DM2 after initiation of GLP-1 receptor agonist therapy.16 A total of 48 individuals completed the survey, which assessed cigarette smoking and associated cravings with the Fagerstrm Test for Nicotine Dependence
First, the creation of tobacco products, such as cigarettes, produces high volumes of carbon dioxide
Quitting smoking can enhance your professional image, potentially opening up new career opportunities and reducing the likelihood of facing hiring restrictions from certain companies
From vaporizer for concentrates and dry herb, batteries for carts pod system for your pods we got you
I recorded Henson Recording
